Covid-19: what is fluvoxamine, this antidepressant that could limit the risk of severe form?

Covid-19: what is fluvoxamine, this antidepressant that could limit the risk of severe form? – The Parisian

A study published in The Lancet Global Health suggests that this antidepressant could be effective in fighting severe forms of Covid-19. “A weak signal in favor of this molecule, but we are very far from the miracle drug”, estimates a scientist.

Fluvoxamine could reduce the risk of being hospitalized or going to the emergency room if you catch Covid-19.  (Illustration) AFP / Thomas Samson
Fluvoxamine could reduce the risk of being hospitalized or going to the emergency room if you catch Covid-19. (Illustration) AFP / Thomas Samson